• FirefoxInstall the new Firefox »
  •  Dow Down 0.47% Nasdaq Down 0.56%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    13.04 Up 0.63(5.08%) Mar 3, 4:00PM EST
    Add to Portfolio
    Prev Close:12.41
    Open:12.38
    Bid:N/A
    Ask:13.61 x 2000
    1y Target Est:24.58
    Beta:5.99
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:12.35 - 13.13
    52wk Range:10.85 - 18.48
    Volume:2,762,873
    Avg Vol (3m):1,662,080
    Market Cap:1.35B
    P/E (ttm):N/A
    EPS (ttm):-1.23
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    KERXUp 5.08%1.35B
    BAXDown 0.77%37.67B
    SHPGUp 1.05%46.74B

    Key Statistics

    Forward P/E (1 yr):652.00
    P/S (ttm):118.76
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.93
    Quarterly EPS Est (Mar-15) :-0.29
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):-0.09

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback